|
Type of alteration | Cell model/type | As species | Reference |
|
Associated to oxidative stress | | | |
DNA strand break | Human fetal lung fibroblast (2BS cells) | AsIII | [121] |
DNA strand break | Human alveolar epithelial type II (L-132) cells | DMAV | [122] |
Single-strand DNA breaks, DNA-protein adducts, sister chromatid exchanges | Human fibroblast cell lines | AsIII | [123] |
Formation of apurinic/apyrimidinic sites | Human alveolar epithelial cell line (L-132) | DMA | [124] |
Induction of 8-OHdG | Human breast cancer MCF-7 adenocarcinoma epithelial cells | AsIII | [125] |
Increases 8-oxo-G levels through (CH3)2AsOO | | DMAV | [126, 127] |
Presence markers for oxidative stress were detected, including 8-oxodG | Mouse bronchiolar Clara cells | DMAV | [128] |
Double-strand DNA breaks | Mammalian cells | | [96] |
|
Epigenetic changes in DNA methylation/histones modification/miRNA expression | | | |
Alteration of methylation in p53 promoter | A549 cell line | AsIII AsV | [106] |
Inductor of hypermethylation of the p16INK4a and RASSF1A CpG islands in nontumor lung tissues (including hyperplasia and adenoma) and lung adenocarcinomas | Lungs of mice exposed during 18 months | AsV | [107] |
Increase of dimethylated H3K9 | Human BEAS-2B cell line | AsIII | [112] |
Increased H3K9 dimethylation and decreased H3K27 tri-methylation (gene silencing), increasing H3K4 tri-methylation (gene-activating mark), increases histone methyltransferase G9a protein levels | Human A549 cell line | AsIII | [112] |
Changes to histone H3 acetylation, DNA promoter methylation, and decreases expression of the DBC1, FAM83A, ZSCAN12, and C1QTNF6 genes | Human nontumorogenic cell lines | | [113] |
Altered expression of hsa-miR-210, -22, -34a, -221, and -222 | Human lymphoblastoid cells | AsIII | [116] |
Reduction in levels of miR-200 | Immortalized p53-knocked down human bronchial epithelial cells (HBECs) | AsIII | [117] |
Decrease in expression of miRNA-9, -181b, -124, and -125b | Chick embryos | AsIII | [118] |
|
Other changes | | | |
Amplification of the dihydrofolate reductase gene | Mouse 3T6 cells | AsIII | [129] |
MAPK activation; phosphorylation of ATF-2 and c-Jun, elevated IL-8 release | Human BEAS 2B line | AsIII | [130] |
Induction of p53-independent expression of GADD45 protein (a G2/M cell-cycle checkpoint protein) | Human BEAS 2B line | AsIII | [131] |
Stabilization of GADD45 alpha mRNA through nucleolin | Human BEAS 2B line | AsIII | [132] |
Mostly decreased expression for transcripts involved in angiogenesis, lipid metabolism, oxygen transport, apoptosis, cell cycle, and immune response | Lung of mice exposed | AsIII | [133] |
Induction of the expression of genes involved with cancer, the cell cycle, cellular proliferation, DNA replication, recombination and repair, lipid metabolism, cell-cell signaling and interaction, molecular transport, and immunological disease pathways in Ogg1−/− mice | Lungs of Ogg1−/− mutant mice exposed | DMAV | [134] |
Enhanced centrosome amplification in p53-compromised cells. Resistance to arsenite-induced G2/M cell cycle arrest and arsenite-induced apoptosis in p53-compromised cells. Reductions in arsenite-induced enhancement of p53, p21, and Gadd45a expressions (at 5–10 μM), Higher (200%) cell colony formation in p53-inhibited BEAS-2B cells (5 μM) | H1355 cells (human lung adenocarcinoma cell line with mutation in p53) Human BEAS-2B line p53-inhibited BEAS-2B cells | AsIII | [135] |
Increased expression of ER-alpha and genes related to estrogen signaling in the fetal lung of female mice | Lung samples from gestation day 18 female fetal C3H mice | AsIII | [136] |
Downregulation of (validated genes): Tpi1, Ldha, and Pgk1. Upregulation of (validated genes): Cox6a2; Variable: Id1, Gpnmb | Rat lung epithelial cell line (L2) | AsIII | [137] |
Increased cell viability (≤0.5 μM). Downregulation of APE1 and Polβ mRNA (above 1 μM) | GM847-immortalized human lung fibroblast | AsIII | [138] |
Increased plating efficiency (cell growth advantage), micronuclei incidence (marker of chromosomal instability), gene amplification (PALA resistance), invasive capabilities; anchorage-independent growth (oncogenic transformation); lost of β4 integrin expression; upregulated phosphorylation of Rb and ERK; decreased expression of p53 protein | h-TERT-immortalized human small airway epithelial cells | AsIII | [139] |
|